The UNC CFAR will conduct an internal review to select the four best candidates for Fiscal Year 2018 funding to move forward with the supplement application.
All interested applicants must submit for review the following:
Documents for internal CFAR review:
Brief proposal no more than 2 pages with specific aims and brief background.
Must have: One paragraph on how this supplement will be used as leverage for RO1 funding…the more specific the better.
Date of submission: Monday Apr 2nd by 5pm.
Send submission to: Dr. Prema Menezes
Details about FY18 supplement opportunity for eligible CFARs:
The CFAR program would like to announce an FY18 supplement opportunity for eligible CFARs. This year we have six scientific areas of interest. Eligible CFARs may submit more than one application in any area BUT no more than four total applications per CFAR. The Developmental Cores should review applications for feasibility and appropriateness of budget in addition to scientific merit as described in the attached announcement.
The NIH is interested in supplement applications from CFARs in the following scientific areas:
- Basic Research on HIV Infection and Persistence
- Infant Immunity for HIV Vaccine Development
- Studies to Delineate Sex Differences in the Incidence of Heart, Lung, Blood, and Sleep Comorbidities in People Living with HIV
- Formative Research on Behavioral Aspects of Novel Biomedical HIV Prevention and Treatment Regimens
- The Evolving Opioid Epidemic and its HIV Consequences
- Implementation of Evidence-Based HIV Interventions and Treatments for Health Disparity Populations
Please see the attached CFAR supplement announcement for more details on the above scientific areas of interest and NIH scientific contacts. CFARs are encouraged but not required to support investigators who have not previously received a CFAR supplement.
The key aspects of this funding opportunity are:
- Applications may be submitted for up to one year with maximum funding per application of up to $150,000 Direct Costs
- Four total applications are permitted per CFAR
- Project directors must be early career investigators who have never received an R-series research grant in HIV/AIDS or established investigators in non-HIV fields
- Each CFAR should have an internal review process to submit the most competitive applications
- CFARs with a high unobligated balance may be disapproved for supplemental funding – please include additional information per the announcement
- CFARs in the first year of a competing renewal must contact program regarding additional requirements
- CFARs in the last year of a competitive segment or in a bridge period are not eligible to apply but could collaborate with another CFAR
- The deadline for applications to be received at NIAID is May 14, 2018
- The earliest anticipated start date is 6/29/18 but may be delayed due to administrative issues
Please note that the number of applications that will be funded for this administrative supplement announcement will be based on funding availability, scientific merit, and program balance. Applications must align with the NIH HIV/AIDS research priorities (NOT-OD-15-137).